Literature DB >> 10993855

Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.

Y Fu1, W C Chang, D Mark, R M Califf, B Mackenzie, C B Granger, E J Topol, M Hlatky, P W Armstrong.   

Abstract

BACKGROUND: Little information exists concerning practice patterns between Canada and the United States in the management of myocardial infarction (MI) patients without ST-segment elevation and unstable angina. METHODS AND
RESULTS: We examined the practice patterns and 1-year outcomes of 2250 US and 922 Canadian patients without ST-elevation acute coronary syndromes in the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb trial. The US hospitals more commonly had on-site facilities for angiography and revascularization. These procedures were performed more often and sooner in the United States than Canada, whereas Canadian patients were more likely to undergo noninvasive stress testing. The length of initial hospital stay was 1 day longer for Canadian than US patients. Recurrent and refractory ischemia was more common in Canada. One-year mortality was comparable between the 2 countries. However, at 6 months, even after baseline differences were accounted for, the (re)MI rate was significantly higher in Canadian than US patients with unstable angina (8.8% versus 5.8%, P:=0.039), as was the composite rate of death or (re)MI (13.1% versus 9.1%, P:=0.016).
CONCLUSIONS: One-year mortality was comparable between Canada and the United States in both MI and unstable angina cohorts despite higher intervention rates in the United States. However, outcomes at 6 months among patients with unstable angina differed. Whereas more frequent coronary interventions were not associated with reduced recurrent MI or death among MI patients without ST elevation, they may favorably affect outcomes in patients with unstable angina.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993855     DOI: 10.1161/01.cir.102.12.1375

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns.

Authors:  Marilyn N Martinez; Iain McGilveray
Journal:  AAPS PharmSci       Date:  2003-10-23

2.  Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.

Authors:  Mohammad I Zia; Shaun G Goodman; Eric D Peterson; Jyotsna Mulgund; Anita Y Chen; Anatoly Langer; Mary Tan; E Magnus Ohman; W Brian Gibler; Charles V Pollack; Matthew T Roe
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

3.  Performance of the 2-hour accelerated diagnostic protocol within the American College of Radiology Imaging Network PA 4005 cohort.

Authors:  Simon A Mahler; Chadwick D Miller; Harold I Litt; Constantine A Gatsonis; Bradley S Snyder; Judd E Hollander
Journal:  Acad Emerg Med       Date:  2015-03-24       Impact factor: 3.451

4.  Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.

Authors:  Wei-Ching Chang; William K Midodzi; Cynthia M Westerhout; Eric Boersma; Judith Cooper; Elliot S Barnathan; Maarten L Simoons; Lars Wallentin; E Magnus Ohman; Paul W Armstrong
Journal:  J Epidemiol Community Health       Date:  2005-05       Impact factor: 3.710

5.  Cardiac intervention rates for older patients with acute myocardial infarction in the United States and Ontario, 2003-2013: a retrospective cohort study.

Authors:  Laura C Yasaitis; Jun Guan; Dennis T Ko; Amitabh Chandra; Therese A Stukel
Journal:  CMAJ Open       Date:  2020-06-11

6.  Acute myocardial infarction: quality of care in rural Alberta.

Authors:  Trustin Domes; Olga Szafran; Cheryl Bilous; Odell Olson; G Richard Spooner
Journal:  Can Fam Physician       Date:  2006-01       Impact factor: 3.275

7.  Comparison of accelerated diagnostic pathways for acute chest pain risk stratification.

Authors:  Jason Stopyra; Anna Catherine Snavely; Brian Hiestand; Brian J Wells; Kristin Macfarlane Lenoir; David Herrington; Nella Hendley; Nicklaus P Ashburn; Chadwick D Miller; Simon A Mahler
Journal:  Heart       Date:  2020-04-08       Impact factor: 5.994

8.  Performance of the EDACS-accelerated Diagnostic Pathway in a Cohort of US Patients with Acute Chest Pain.

Authors:  Jason P Stopyra; Chadwick D Miller; Brian C Hiestand; Cedric W Lefebvre; Bret A Nicks; David M Cline; Kim L Askew; Robert F Riley; Gregory B Russell; James W Hoekstra; Simon A Mahler
Journal:  Crit Pathw Cardiol       Date:  2015-12

Review 9.  Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Ibtihal Fadhil; Kathryn Taubert; Masoumeh Sadeghi; Nanette K Wenger; Nigel S Tan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2017-09-21       Impact factor: 32.419

10.  The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China.

Authors:  Andrew Moran; Dong Zhao; Dongfeng Gu; Pamela Coxson; Chung-Shiuan Chen; Jun Cheng; Jing Liu; Jiang He; Lee Goldman
Journal:  BMC Public Health       Date:  2008-11-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.